Citi downgraded Loxo Oncology (NASDAQ: LOXO) from Buy to Neutral with a price target of $45.00 (from $49.00).Analyst Dr. Yifal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE